Using probiotics to reduce heart disease risk in people with HIV who drink heavily

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical trial investigates the effects of a probiotic pill on gut health in individuals living with HIV who consume alcohol heavily. The study aims to determine if the probiotic can restore healthy gut bacteria, reduce inflammation, and lower the risk of cardiovascular disease and mortality. By focusing on the relationship between alcohol, gut dysbiosis, and heart health, the trial will assess changes in microbial profiles and inflammatory markers among participants. A total of 250 participants will be enrolled to evaluate the efficacy of the intervention compared to a placebo.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* HIV infected

Exclusion Criteria:

* Not fluent in English

Where it's running

• Vanderbilt University Medical Center
  Nashville, Tennessee, United States Recruiting

Study contacts

• Study coordinator: Grace Wallace, BS
• Email: grace.wallace@vumc.org
• Phone: 615-936-5356

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Microbiota Interventions for Accelerated Aging in People with HIV on Alcohol

  This study tests whether two safe dietary supplements—Limosilactobacillus reuteri and blueberry extract—can affect immune aging markers in people with HIV who recently used alcohol.

  Recruiting Phase 1/2 Louisiana State University Health Sciences Center in New Orleans · New Orleans, Louisiana · NCT07462767

• Examining drug interactions in older adults living with HIV

  This study looks at how different medications interact in older adults with HIV to see if we can improve their treatment plans.

  Recruiting IRCCS Azienda Ospedaliero-Universitaria di Bologna · Bologna · NCT06717581

• Reducing alcohol use in PrEP users through SBIRT intervention

  This study is testing if a program that helps people cut down on drinking can improve the health of those using PrEP for HIV prevention and help them stick to their medication.

  Recruiting University of Louisville · Louisville, Kentucky · NCT06005298

• Understanding chronic kidney disease in Sub-Saharan Africa

  This study is trying to understand how common chronic kidney disease is in Sub-Saharan Africa and what factors might be causing it by looking at the health and lifestyle of adults in the Bagamoyo district.

  Recruiting Swiss Tropical & Public Health Institute · Bagamoyo, Pwani Region · NCT05881447

• Lowering cholesterol and inflammation in HIV patients using Bempedoic acid

  This study is testing if a medication called Bempedoic acid can lower cholesterol and inflammation in people over 40 with HIV who have heart disease or are at risk for it.

  Recruiting at 3 sites Phase 2 University of California, San Francisco · Los Angeles, California and 2 other locations · NCT05488431

• Effect of Periodontal Therapy on Gut Microbes and Inflammation in People with Inflammatory Bowel Disease

  This study tests whether treating gum disease in people with inflammatory bowel disease can influence the gut microbiome and markers of systemic inflammation.

  Recruiting University of Turin, Italy · Turin, Turin · NCT07905859

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.